(MENAFN- ProactiveInvestors - Australia) Cellmid Ltd (ASX:CDY) has been granted a trading halt by the ASX, pending details of a capital raising.
The company recently achieved record sales for its FGF5 inhibitor hair loss products during the first quarter of the 2017 financial year.
For the first time ever, sales exceeded the million-dollar mark for the quarter
Australian sales grew by 115%, with the new national advertising program showing strong results.
The halt will remain in place until the opening of trade on Friday 28th October 2016, or earlier if an announcement is made to the market.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.